MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
466.79
+8.89
+1.94%
After Hours: 468.00 +1.21 +0.26% 19:04 06/09 EDT
OPEN
460.36
PREV CLOSE
457.90
HIGH
471.23
LOW
456.97
VOLUME
284.30K
TURNOVER
--
52 WEEK HIGH
628.92
52 WEEK LOW
294.07
MARKET CAP
13.33B
P/E (TTM)
29.37
1D
5D
1M
3M
1Y
5Y
1D
Citrini sees new upside in healthcare stocks, updates basket
Seeking Alpha · 17h ago
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
PR Newswire · 1d ago
MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026
Barchart · 1d ago
Weekly Report: what happened at MEDP last week (0601-0605)?
Weekly Report · 1d ago
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings (MEDP) and Upcoming Lead Plaintiff Deadline of June 8, 2026
Barchart · 2d ago
How Investors Are Reacting To Medpace Holdings (MEDP) Executive Shakeup Amid Securities Class Action Surge
Simply Wall St · 2d ago
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR Newswire · 4d ago
MEDP Deadline: Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their Rights
Barchart · 4d ago
More
About MEDP
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.